Annual report pursuant to Section 13 and 15(d)

Revenue Recognition (Tables)

v3.20.1
Revenue Recognition (Tables)
12 Months Ended
Dec. 31, 2019
Revenue Recognition [Abstract]  
Schedule of revenue recognition
    Years Ended December 31,  
    2019     2018  
Products:            
Disposable products:                
Functional neurosurgery   $ 6,884,085     $ 5,351,557  
Biologics and drug delivery     1,458,850       913,424  
Therapy     96,925        
       Capital equipment     1,036,505       420,039  
Total product revenue     9,476,365       6,685,020  
Services:                
Biologics and drug delivery     889,702       175,223  
Therapy     225,000       100,000  
Capital equipment and other     625,870       393,023  
Total service revenue     1,740,572       668,246  
Total revenue   $ 11,216,937     $ 7,353,266